Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MCD
7. MGM
8. NVDA
9. COST
10. ACAD

Go back to Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
(NASDAQ: ALLO) Delayed: 1.67 --0 (-0%)
Previous Close $1.67    52 Week High $ 
Open $1.67    52 Week Low $ 
Day High $1.72    P/E N/A 
Day Low $1.60    EPS $ 
Volume 7,789,649